ASCO Guidelines

An interview with Dr. Davendra Sohal from the Cleveland Clinic on the guideline update regarding second-line therapy for patients with metastatic pancreatic cancer. Read the full guideline at www.asco.org/gastrointestinal-cancer-guidelines

An interview with Dr. Neelima Denduluri from US Oncology, Virginia Cancer Specialists, on the key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer. Read the full guideline on www.asco.org/breast-cancer-guidelines

An interview with Dr. Supriya Mohile from University of Rochester on the guideline published in JCO which provides guidance regarding the practical assessment and management of vulnerabilities in older patients undergoing chemotherapy. To read the full guideline go to www.asco.org/supportive-care-guidelines.

An interview with Dr. Neelima Denduluri, Dr. Manish Shah, Dr. Mariana Chavez Mac Gregor, and Tom Oliver discussing the ASCO Clinical Practice Guidelines program, methodology, panel representation, and vision for the future. Read more at www.asco.org/guidelines

An interview with Dr. Nahla Gafer from Radiation & Isotope Center in Sudan on the Palliative Care in the Global Setting: ASCO Resource-Stratified Guideline.

The purpose of this new resource-stratified guideline is to provide expert guidance to clinicians and policymakers on implementing palliative care in resource-constrained settings and is intended to complement the Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Update of 2016. It is the view of the ASCO that health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available. The guideline is intended to complement but not replace local guidelines.

Read the full guideline at www.asco.org/resource-stratified-guidelines

An interview with Dr. Paul Hesketh from Lahey Hospital and Medical Center on the antiemetics guideline update published in 2017. The guideline update expands the recommendations to include olanzapine and neurokinin 1 receptor antagonists. Read the full guideline at www.asco.org/supportive-care-guidelines

An interview with Dr. Timothy Gilligan from Taussig Cancer Institute and Institute and the Center for Excellence in Healthcare Communication, Cleveland Clinic, Cleveland, OH on the guideline providing guidance to oncology clinicians on how to use effective communication to optimize the patient-clinician relationship, patient and clinician well-being, and family well-being. Read the full guideline at www.asco.org/supportive-care-guidelines

An interview with Dr. Betty R. Ferrell of City of Hope Medical Center on the guideline "Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update" which provides evidence-based recommendations to oncology clinicians, patients, family and friend caregivers, and palliative care specialists on the integration of palliative care into standard oncology care for all patients diagnosed with cancer.

A guideline on palliative care in the global setting is currently in press with the Journal of Global Oncology and there will be an episode on this topic when it publishes.

Read the full guideline at www.asco.org/supportive-care-guidelines

An interview with Dr. Alison W. Loren of Perelman School of Medicine of the University of Pennsylvania on the ASCO guideline update which provides current recommendations about fertility preservation for adults and children with cancer. Read the full guideline at www.asco.org/survivorship-guidelines

An interview with Dr. Michael J. Morris from Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine on the ASCO clinical practice guideline which addresses abiraterone or docetaxel with androgen-deprivation therapy (ADT) for metastatic prostate cancer that has not been treated (or has been minimally treated) with testosterone-lowering agents. Read the full guideline at www.asco.org/genitourinary-cancer-guidelines